A multicentre evaluation of the CA 15-3 assay, CA 19-9 assay and CA 125 II assay on the Bayer Immuno 1 System.
Römer M, Haeckel R, Brux B, Sinha P, Raiko I, Krieg M, Stark M, Seidel D, Hübner U, Schmitz G.
Römer M, et al. Among authors: haeckel r.
Eur J Clin Chem Clin Biochem. 1997 Aug;35(8):637-44.
Eur J Clin Chem Clin Biochem. 1997.
PMID: 9298356
Clinical Trial.
The analytical performance of the tumour markers CA 15-3 assay, CA 19-9 assay and Ca 125 II assay on the Bayer Immuno I System was studied according to a revised version of the ECCLS guidelines (Haeckel R. In: Evaluation methods in laboratory medicine, Weinheim, VCH …
The analytical performance of the tumour markers CA 15-3 assay, CA 19-9 assay and Ca 125 II assay on the Bayer Immuno I System was studied a …